Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2021 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? Let's analyze the transcript. Management discusses several things: Medicare Advantage enrollment growth, telesales organization, digital business, IFP business, partnerships with Walgreens, Costco, SilverSneakers, Cardinal Health, Adherus Health, Cipher Health, etc. They talk about carriers' focus on enrollment quality. They talk about their own investments in agent training, QA, etc. They talk about the IFP market benefiting from the American Rescue Plan Act. They talk about their own online enrollments. But the key is: does management narrate what counterparties are themselves doing and scaling? For example, do they talk about carriers expanding their Medicare Advantage plans, or partners like Walgreens rolling out something? They mention expanding relationships with Walgreens, Costco, SilverSneakers, and adding new partnerships. But they don't describe those partners' own trajectories in detail. They mention that carriers are evaluating broker performance on quality, but that's not about scaling their own operations. They talk about the IFP market tailwinds from legislation, but that's a macro condition. The question specifically asks: "does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort?" Management's forward account is mostly about their own actions: hiring agents, training, QA, online enrollment growth, customer center, etc. They mention partnerships but not their scaling.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.